Home > Journals > Minerva Psichiatrica > Past Issues > Minerva Psichiatrica 2006 March;47(1) > Minerva Psichiatrica 2006 March;47(1):11-24

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PSICHIATRICA

A Journal on Psychiatry, Psychology and Psychopharmacology


Official Journal of the Italian Society of Social Psychiatry
Indexed/Abstracted in: EMBASE, e-psyche, PsycINFO, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  


Minerva Psichiatrica 2006 March;47(1):11-24

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: Italian

Neuroendocrine dysfunction in patients with mood disorders

Mazza M. 1, Bria P. 1, Janiri L. 1, Mazza S. 2

1 Istituto di Psichiatria e Psicologia Università Cattolica del Sacro Cuore, Roma 2 Istituto di Neurologia Università Cattolica del Sacro Cuore, Roma


PDF  


Mood disorders represent the most widespread prevalent and expensive psychiatric disorders. For a long time, the neuroendocrine system and the distribution of hormones through the brain and their modulatory role and influence in behavior and mood have been studied. The most important changes associated with mood disorders concern the hypothalamic-pituitary-adrenal (HPA), the hypothalamic-pituitary-thyroid (HPT), the hypothalamic-pituitary-GH (HPGH) and the hypothalamic-pituitary-gonadal (HPGn) axes. The intriguing data obtained from studies focusing on central neuropeptidergic circuits and peripheral hormone systems have been very useful in understanding the pathophysiology of mood disorders, although additional researches are needed to confirm these findings. All these data underline the importance of neuroendocrine dysfunctions in both pathophysiology of mood disorders and in the development of new pharmacotherapies.

top of page

Publication History

Cite this article as

Corresponding author e-mail